Hidradenitis Suppurativa News

Higher-quality studies are needed to determine the efficacy of procedural interventions in pediatric hidradenitis suppurativa, according to a systematic review.

The European Medicines Agency has issued a positive opinion of Cosentyx for the treatment of adults with moderate to severe hidradenitis suppurativa and recommends a marketing authorization be granted, Novartis announced in a release.

Patients with hidradenitis suppurativa expressed six emergent themes that impact their access to proper health care, according to a study.

NEW ORLEANS — While prevalent among women with hidradenitis suppurativa, polycystic ovary syndrome is not associated with increased hidradenitis suppurativa disease severity, according to a poster presented here.

The American Academy of Dermatology Annual Meeting this year included clinical trial announcements and informative lectures in a wide variety of indications.

NEW ORLEANS — Izokibep, a novel interleukin-17 inhibitor, has shown dramatic responses in hidradenitis suppurativa treatment in an early phase 2 study, according to a speaker at the American Academy of Dermatology Annual Meeting.

NEW ORLEANS — Phase 2 clinical trial results confirmed the benefit of upadacitinib, a selective Janus kinase 1 inhibitor, in the treatment of hidradenitis suppurativa, according to a presentation here.

NEW ORLEANS — A novel monoclonal antibody could be a promising treatment for hidradenitis suppurativa as phase 2 clinical trial results showed an improvement in total abscess and nodule count after 16 weeks of treatment.

Subtle gaps in knowledge among ED providers treating pediatric patients with hidradenitis suppurativa suggests a need for educational intervention, according to a study.

Results from an open-label extension of a phase 2 study evaluating povorcitinib in adults with hidradenitis suppurativa showed participants maintained average efficacy, Incyte announced in a press release.